MNKKQ
Mallinckrodt Plc

6,857
Loading...
Loading...
Mallinckrodt Plc engages in the development, manufacture, marketing, and distribution of both branded and generic specialty pharmaceutical products. It operates through the Specialty Brands and Specialty Generics segments. The Specialty Brands segment markets branded pharmaceutical products for autoimmune and rare diseases in the specialty areas of neurology, rheumatology, hepatology, nephrology, pulmonology, ophthalmology, and oncology; immunotherapy and neonatal respiratory critical care therapies; and gastrointestinal products. The Specialty Generics segment consists of niche specialty generic drugs and active pharmaceutical ingredients. The company was founded by Gustavo Mallinckrodt, Otto Mallinckrodt and Edward Mallinckrodt in 1867 and is headquartered in Dublin, Ireland.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Mallinckrodt Plc?
What is the 52-week high for Mallinckrodt Plc?
What is the 52-week low for Mallinckrodt Plc?
What is Mallinckrodt Plc stock price today?
What was Mallinckrodt Plc stock price yesterday?
What is the PE ratio of Mallinckrodt Plc?
What is the Price-to-Book ratio of Mallinckrodt Plc?
What is the 50-day moving average of Mallinckrodt Plc?

Latest MNKKQ News

View
No MNKKQ news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.